No abstract

Increased concern over the risk resorcinol (RS) pose to ecology and humans, led to its position in European Union Category 1 list of endocrine disruptors. Legal measures restricted RS utilization and hence crucial to monitor its levels in the environment. Herein we report development of highly efficient and economically viable electrochemical sensor for quantitative determination of RS based on 77Maghemite/MultiWall Carbon Nanotube (M/MWCNT) modified carbon paste electrode. M/MWCNT was synthesized via strategic IR irradiation for the first time, a promising approach to overcome other complicated chemical routes. Powder X‐ray diffraction (PXRD), Transmission electron microscopy (TEM), Field emission scanning electron microscopy (FESEM) and Energy dispersive X‐ray (EDX) were used for characterization. Using Differential Pulse Voltammetry (DPV), we report the lowest detection limit at 0.02 μM. The potential application of the sensor was accomplished as a result of excellent recoveries made from real samples fortified with RS. Results indicated the proficiency of the sensor reliable for rapid, onsite monitoring of RS water contamination and in biological matrices.

No abstract

No abstract

No abstract

Naringenin (NR) displays strong antioxidant and numerous pharmacological activities, mitigating severity of metabolic‐syndromes without undesirable side‐effects. With the upsurge of interest in administering NR as diet‐supplement antioxidant, in this work for the first time we implemented functionalized‐MWCNT/Nileblue‐composite on carbon paste electrode (fMWNCT/NB/MCPE), as electrochemical sensor for catalytic NR oxidation. Integrated properties of fMWCNT/NB and their consonance with CPE, led to lowering of Rct value with fast‐kinetics and diminution of over‐potential. NR determination was due to electrical‐conductivity, π‐π and electrostatic‐forces that magnified anodic current by 5.5 fold. In the pH range 3.0 to 10.0 NR undergoes irreversible oxidation via transfer of 1e−/H+. Critical parameters, namely, pH and scan rate were assessed to reinforce differential pulse voltammtery (DPV) sensitivity for quantitative measurements. Sensor's selectivity, stability, accuracy and reproducibility were determined. Finally its viability in quantifying NR was validated by scrutinizing NR fortified fruit juices, as real sample matrices.

Diabetes mellitus is a physiological and metabolic disorder affecting millions of people worldwide, associated with global morbidity, mortality, and financial expenses. Long-term complications can be avoided by frequent, continuous self-monitoring of blood glucose. Therefore, this review summarizes the current state-of-art glycemic control regimes involving measurement approaches and basic concepts. Following an introduction to the significance of continuous glucose sensing, we have tracked the evolution of glucose monitoring devices from minimally invasive to non-invasive methods to present an overview of the spectrum of continuous glucose monitoring (CGM) technologies. The conveniences, accuracy, and cost-effectiveness of the real-time CGM systems (rt-CGMs) are the factors considered for discussion. Transdermal biosensing and drug delivery routes have recently emerged as an innovative approach to substitute hypodermal needles. This work reviews skin-patchable glucose monitoring sensors for the first time, providing specifics of all the major findings in the past 6 years. Skin patch sensors and their progressive form, i.e., microneedle (MN) array sensory and delivery systems, are elaborated, covering self-powered, enzymatic, and non-enzymatic devices. The critical aspects reviewed are material design and assembly techniques focusing on flexibility, sensitivity, selectivity, biocompatibility, and user-end comfort. The review highlights the advantages of patchable MNs' multi-sensor technology designed to maintain precise blood glucose levels and administer diabetes drugs or insulin through a "sense and act" feedback loop. Subsequently, the limitations and potential challenges encountered from the MN array as rt-CGMs are listed. Furthermore, the current statuses of working prototype glucose-responsive "closed-loop" insulin delivery systems are discussed. Finally, the expected future developments and outlooks in clinical applications are discussed.

No abstract